First Medicare-Accepted Oral Appliance Treatment for All Severities of Obstructive Sleep Apnea in Adults
LITTLETON, Colo., April 9, 2024 -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities…
